510(k) · Cleared
ClearedHemosil D-Dimer
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Instrumentation Laboratory CO · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Cleared on Mar 10, 2005 as substantially equivalent to K972696 (Instrumentation Laboratory CO, 1997) after a 31-day review. Its family tree reaches back 2 generations to 1995. 1 later device descends from it.
- Decided
- Mar 10, 2005
- Review
- 31 days
- Class
- Class II
- Product code
- DAP
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K945642 (1995). 1 later device descends from it, 1 citing it directly.
- Root · 2 generations backK945642 Agen Dimertest Gold EiaAgen Biomedical, Ltd. · 1995
- 1 generation backK972696 IL Test D-DimerInstrumentation Laboratory CO · 1997
- This deviceK050278 Hemosil D-DimerInstrumentation Laboratory CO · 2005
- Descendant · cites it directly · 0 of its ownK073042 Hemosil D-DimerInstrumentation Laboratory · 2008
Most influential descendants
Showing 1 of 1 · See all- K073042Hemosil D-DimerInstrumentation Laboratory · 2008 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K945642 | Agen Dimertest Gold Eia | Agen Biomedical, Ltd. | 1995 | — |
| −1 | K972696 | IL Test D-Dimer | Instrumentation Laboratory CO | 1997 | — |
| 0 (this device) | K050278 | Hemosil D-Dimer | Instrumentation Laboratory CO | 2005 | — |
| +1 | K073042 | Hemosil D-Dimer | Instrumentation Laboratory | 2008 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DAP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DAP device
- #1 K253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)score 13.0 · 5 generations · no Class I recall
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K972696 | IL Test D-DimerSummary page 1…Control Device Class: Class Ii Regulation No.: 864.7320 Product Code: DAP Panel: Hematology Predicate Device: HemosIL D-Dimer K972696 Device Indications for Use/Description: HemosIL D-Dimer is an automated latex enhanced immunoassay for the quantitative determina… | 1997 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K073042 | Hemosil D-Dimer | 2008 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 7.3 years on median.
- None of the 2 ancestors has a recall.
- Of its descendants, K073042 (Instrumentation Laboratory, 2008) has gone furthest, with 0 descendants of its own.
- 4 other devices also cite its predicate K972696.
How does its category compare?
All DAP devicesDAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DAP
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · DAP
127in 2008
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DAP
2in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DAP
2in 2025
MAUDE reports naming product code DAP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 4 |
| 2008 | 3 | 127 | 0 | 10 |
| 2009 | 1 | — | 0 | 13 |
| 2010 | 2 | — | 0 | 9 |
| 2011 | 1 | — | 0 | 14 |
| 2012 | 1 | — | 0 | 10 |
| 2013 | 0 | — | 0 | 8 |
| 2014 | 1 | — | 0 | 9 |
| 2015 | 1 | — | 1 | 38 |
| 2016 | 2 | — | 0 | 20 |
| 2017 | 1 | — | 0 | 17 |
| 2018 | 0 | — | 0 | 5 |
| 2019 | 0 | — | 0 | 9 |
| 2020 | 0 | — | 0 | 11 |
| 2021 | 0 | — | 1 | 7 |
| 2022 | 0 | — | 0 | 30 |
| 2023 | 0 | — | 0 | 4 |
| 2024 | 0 | — | 0 | 1 |
| 2025 | 0 | — | 2 | 2 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
HemosIL D-Dimer is an automated latex enhanced immunoassay for the quantitative determination of D-Dimer in human citrated plasma on IL Coagulation Systems as an aid in the diagnosis of venous thromboembolism (VTE) [deep venous thrombosis (DVT) and pulmonary embolism (PE)].
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K050278 · printed Nov 6, 2026
Cite this page
510(k) Report. “K050278: Hemosil D-Dimer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K050278
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026